Fair Value Calculator Fair Value Calculator
EN DE

0554 (0554) Fair Value & Analysis

Industrials · Market cap HK$875M

0 0554 0554 · HK
PriceHK$0.2030
Fair ValueHK$0.1600
Upside-21.2%
Quality38/100
Evidence: Medium Range HK$0.1600 – HK$0.4300

Fair value as of: Jul 2, 2026

From 14 valuation models · updated today

Share price +1.5% over the past month.

Price vs Fair Value (12 months)

HK$0.3100 HK$0.1840 Fair Value HK$0.1600 Jun 2025 Jun 2026

12‑month range HK$0.1840 – HK$0.3100 · fair‑value band HK$0.1600 – HK$0.4300 · the HK$0.2030 price screens above the HK$0.1600 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0554 (0554) currently trades at HK$0.2030, while our model-based Fair Value estimate is HK$0.1600 — implying the stock looks roughly 21.2% overvalued today. We read business quality at 38/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0554 generated revenue of HK$7.2B at a net margin of -2.2%. Revenue grew 32.9% year over year. It earns a return on equity of -10.6%. Net debt stands at HK$3.8B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$7.2B
Revenue growth (YoY) +32.9%
Net margin -2.2%
Return on equity -10.6%
Free cash flow HK$848M FY2025
Operating margin 1.3%
More key figures
EPS (TTM) HK$-0.0300
EPS growth (YoY) -22.6%
Net debt HK$3.8B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0554 reported revenue of HK$7.2B in FY2025 versus HK$2.0B in FY2021, a compound +38.4%/yr. Reported net income was −HK$162M in FY2025.

Revenue +38.4%/yr
FY21 HK$2.0B
FY22 HK$695M
FY23 HK$949M
FY24 HK$3.6B
FY25 HK$7.2B
Net income
FY21 −HK$16.0M
FY22 HK$207K
FY23 −HK$35.1M
FY24 −HK$181M
FY25 −HK$162M

Is 0554 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Honeywell International Inc HON C$25.91 C$16.17 -38%
Hitachi, Ltd HTHIY $29.38 $23.57 -20%
CITIC Limited 0267 HK$12.30 HK$37.22 +203%
0019 0019 HK$81.70 HK$13.77 -83%
CK Hutchison Holdings 0001 HK$68.20 HK$146.23 +114%
Itaúsa S.A ITSA3 R$13.05 R$13.52 +4%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0554 (0554) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.1600 versus a price of HK$0.2030 — about −21% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 0554?
Our model-based fair value for 0554 is HK$0.1600 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2030.
What is the quality score of 0554?
0554 has a Quality Score of 38/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0554 (0554)?
0554 reported trailing-twelve-month revenue of about HK$7.2B (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 0554?
The net profit margin of 0554 is about -2.2%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.